NCT00425282View on ClinicalTrials.gov

A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.

PHASE3CompletedINTERVENTIONAL
Enrollment

566

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
EpilepsyEpilepsy, FocalSeizure DisorderComplex Partial SeizuresEpilepsy, Complex Partial
Interventions
DRUG

RWJ-333369

All Listed Sponsors
lead

SK Life Science, Inc.

INDUSTRY

NCT00425282 - A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures. | Biotech Hunter | Biotech Hunter